Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M51.3Revenue $M0.0Net Margin (%)-141,705.0Z-Score-5.8
Enterprise Value $M19.1EPS $-0.3Operating Margin %-328,543.8F-Score2
P/E(ttm))0Cash Flow Per Share $-1.4Pre-tax Margin (%)-146,132.9Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %0Quick Ratio4.8Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %-24.6Current Ratio4.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-29.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-124.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M90.6ROI % (ttm)-76.6Gross Margin Increase y-yY

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEZSJean-Marie Eveillard 2010-03-31 Sold Out $4.8 - $5.58
($4.98)
$ 0.57-774%Sold Out0
AEZSJean-Marie Eveillard 2009-12-31 Reduce$4.74 - $7.5
($6.12)
$ 0.57-974%Reduce -91.09%124,518
AEZSJean-Marie Eveillard 2009-09-30 Buy 0.02%$5.34 - $16.98
($9.72)
$ 0.57-1605%New holding1,397,897
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEZS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JrgenDirector 2014-11-12Buy3,100$0.61-4.92 view
Ernst, JrgenDirector 2014-11-12Buy60,000$0.6-3.33 view
Ernst, JrgenDirector 2014-11-12Buy39,400$0.62-6.45 view
Ernst, JrgenDirector 2014-11-12Buy7,600$0.61-4.92 view
Ernst, JrgenDirector 2014-11-12Buy14,900$0.61-4.92 view
Egbert, CarolynDirector 2014-11-10Buy5,000$0.59-1.69 view
Egbert, CarolynDirector 2014-11-10Buy9,000$0.59-1.69 view
Egbert, CarolynDirector 2014-11-10Buy30,253$0.580 view
Egbert, CarolynDirector 2014-11-10Buy9,144$0.571.75 view
Egbert, CarolynDirector 2014-11-10Buy12,603$0.571.75 view

Press Releases about AEZS :

    Quarterly/Annual Reports about AEZS:

      News about AEZS:

      Articles On GuruFocus.com
      Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
      Can Keryx Succeed Without Partnership? Apr 24 2012 
      Keryx Still Has High Potential from Zerenex Apr 12 2012 
      comment on AEZS Oct 26 2011 
      Opportunistic Coat-tailing Jan 05 2010 


      More From Other Websites
      Nasdaq stocks posting largest volume increases Apr 23 2015
      April 23, 2015 Aeterna Zentaris to Present at 2015 Bloom Burton & Co. Healthcare Investor Conference... Apr 23 2015
      Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris... Apr 23 2015
      Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris... Apr 23 2015
      Can the Uptrend Continue for AEterna Zentaris (AEZS)? - Tale of the Tape Apr 16 2015
      April 16, 2015 Aeterna Zentaris Files Additional Patent Application to Strengthen IP Protection of... Apr 16 2015
      Aeterna Zentaris Files Additional Patent Application to Strengthen IP Protection of Zoptarelin... Apr 16 2015
      Aeterna Zentaris Files Additional Patent Application to Strengthen IP Protection of Zoptarelin... Apr 16 2015
      BIND Therapeutics (BIND) Looks Good: Stock Adds 6.1% - Tale of the Tape Apr 15 2015
      Aeterna Zentaris to Advance Hormone Drug to Phase III Study - Analyst Blog Apr 14 2015
      Sequenom (SQNM) Looks Good: Stock Gains 6.3% in Session - Tale of the Tape Apr 14 2015
      April 13, 2015 Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen™ in AGHD... Apr 13 2015
      Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen™ in AGHD Following... Apr 13 2015
      Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen™ in AGHD Following... Apr 13 2015
      March 31, 2015 Aeterna Zentaris Signs Transfer Agreement of its Discovery Library with the Medical... Mar 31 2015
      Aeterna Zentaris Signs Transfer Agreement of its Discovery Library with the Medical University of... Mar 31 2015
      Aeterna Zentaris Signs Transfer Agreement of its Discovery Library with the Medical University of... Mar 31 2015
      AETERNA ZENTARIS INC. Financials Mar 25 2015
      Zacks Rank #1 Additions for Wednesday - Tale of the Tape Mar 25 2015
      Aeterna Zentaris Inc. (AEZS) in Focus: Stock Jumps 5.3% - Tale of the Tape Mar 23 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK